All Updates

All Updates

icon
Filter
Funding
Biodesix announces USD 55 million underwritten offer and private placement
AI Drug Discovery
Apr 5, 2024
This week:
Product updates
Meta introduces Meta Credits digital currency for Horizon Worlds
Metaverse Platforms
Today
Product updates
Liquid AI launches STAR framework for AI model architecture optimization
Foundation Models
Today
Funding
9fin raises USD 50 million in Series B funding to expand US operations
Capital Markets Tech
Yesterday
Partnerships
Shastic partners with MeridianLink to provide AI workflow automation for financial institutions
Workflow Automation Platforms
Yesterday
Funding
KisoJi Biotechnology raises CAD 41 million to develop oncology candidate
AI Drug Discovery
Yesterday
M&A
Deel acquires UK money transfer startup Atlantic Money for undisclosed sum
Remote Work Infrastructure
Yesterday
Funding
Acorai raises EUR 4.2 million in funding to advance clinical studies
Next-gen Medical Devices
Yesterday
Product updates
Bosch announces Light Drive, an AR solution for all-day smart glasses
Extended Reality
Yesterday
Product updates
Partnerships
Vuzix expands OSHA collaboration; launches upgraded M400 AR smart glasses
Extended Reality
Yesterday
Product updates
StrikerVR launches pre-orders for consumer-facing Mavrik haptic VR gun
Extended Reality
Yesterday
AI Drug Discovery

AI Drug Discovery

Apr 5, 2024

Biodesix announces USD 55 million underwritten offer and private placement

Funding

  • Biodesix has announced an underwritten stock offering of 17,391,832 shares at USD 1.15 per share. The company has also announced a private placement of 760,857 shares of Series A Non-Voting Convertible Preferred Stock at USD 46.00 per share. The gross proceeds from these transactions are expected to be USD 55 million.

  • The underwritten offering and placement is jointly managed by TD Cowen, William Blair, Canaccord Genuity, and Lake Street Capital Markets. Certain management members, directors, and funds affiliated with these directors are reported to be participating in the private placement. The closing date of the offering is to be around April 9, 2024, subject to customary closing conditions and stockholder approval.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.